SKRAVERO Trademark

Trademark Overview

On Saturday, March 24, 2018, a trademark application was filed for SKRAVERO with the United States Patent and Trademark Office. The USPTO has given the SKRAVERO trademark a serial number of 79233963. The federal status of this trademark filing is REGISTERED as of Tuesday, May 31, 2022. This trademark is owned by NOVARTIS AG. The SKRAVERO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
skravero

General Information

Serial Number79233963
Word MarkSKRAVERO
Filing DateSaturday, March 24, 2018
Status700 - REGISTERED
Status DateTuesday, May 31, 2022
Registration Number6741513
Registration DateTuesday, May 31, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements

Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Sunday, October 2, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 15, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 15, 2022FINAL DISPOSITION PROCESSED
Wednesday, August 31, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 31, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 31, 2022REGISTERED-PRINCIPAL REGISTER
Monday, March 21, 2022NOTIFICATION PROCESSED BY IB
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 23, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 6, 2021FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
Thursday, October 1, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 25, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Saturday, July 18, 2020ATTORNEY REVIEW COMPLETED
Friday, July 17, 2020CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Friday, July 17, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, June 26, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 3, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 3, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, May 27, 2020REG. CANCELLED - RESTORED TO PENDENCY
Wednesday, May 27, 2020ASSIGNED TO PETITION STAFF
Tuesday, May 26, 2020REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Monday, April 15, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 15, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, December 20, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Friday, November 9, 2018NOTIFICATION PROCESSED BY IB
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 10, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, September 23, 2018ASSIGNED TO LIE
Saturday, September 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 21, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 21, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 3, 2018REFUSAL PROCESSED BY IB
Tuesday, July 10, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 10, 2018REFUSAL PROCESSED BY MPU
Saturday, June 30, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 29, 2018NON-FINAL ACTION WRITTEN
Tuesday, June 26, 2018ASSIGNED TO EXAMINER
Saturday, June 16, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, June 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 11, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 7, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

skravero preparations pharmaceutical system prevention treatment diseases disorders anti pharmaceuticals musculo